ストックスクリーナーアプリを入手
0.3838
0.31%
-0.0012
前日終値:
$0.385
開ける：
$0.38
24時間の取引高:
222.39K
Relative Volume:
0.07
時価総額：
$2.36M
収益：
$3.29M
当期純損益:
$-3.09M
株価収益率:
-0.312
EPS:
-1.23
ネットキャッシュフロー:
$-2.46M
1週間 パフォーマンス:
-12.77%
1か月 パフォーマンス:
-23.09%
6か月 パフォーマンス:
-38.68%
1年 パフォーマンス:
-64.13%
1日の値動き範囲:
$0.3704
$0.3945
1週間の範囲:
$0.362
$0.4506
52週間の値動き範囲:
$0.362
$1.27
Nanovibronix Inc Stock (NAOV) Company Profile
NAOV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.3838 | 2.36M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Nanovibronix Inc (NAOV) 最新ニュース
NanoVibronix files to sell shares of Series G Convertible Preferred Stock, warrants - MSN
Oncolytics Biotech receives Nasdaq non-compliance notice - MSN
NanoVibronix Completes Merger with ENvue Medical Holdings - TipRanks
NanoVibronix Acquires ENvue Medical Holdings To Expand Medical Device Market Reach - Nasdaq
FDA Approves MED-EL’s Sonnet 3 Audio Processor for Cochlear Implants - MPO-mag
NanoVibronix Acquires Enteral Feeding Company ENvue - MPO-mag
NanoVibronix Acquires ENvue Medical Holdings - citybiz
NanoVibronix Completes ENvue Medical Acquisition -February 14, 2025 at 10:54 am EST - Marketscreener.com
NanoVibronix acquires enteral tech firm ENvue Medical - Investing.com
NanoVibronix completes acquisition of ENvue Medical - TipRanks
NanoVibronix acquires enteral tech firm ENvue Medical By Investing.com - Investing.com UK
Strategic Medical Tech Acquisition: NanoVibronix Takes Over Enteral Feeding Pioneer ENvue - StockTitan
Ascendis Pharma targets €200M SKYTROFA revenue and expands YORVIPATH globally in 2025 - MSN
Ocean Biomedical reports unregistered equity sales - MSN
IMUNON names Douglas Faller as chief medical officer - MSN
Pilot Phase Ends for NanoVibronix’s UroShield Study - MPO-mag
NanoVibronix Provides Year-End Business Update - ACCESS Newswire
NanoVibronix Announces Presentation of PainShield(R) to HCPCS Workgroup at CMS - ACCESS Newswire
NAOV’s 2023 Market Dance: Down -23.05% – Time to Invest? - The InvestChronicle
In the Green: MKDWELL Tech Inc (MKDW) Closes at 0.37, Up/Down -20.43 from Previous Day - The Dwinnex
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Daily Market Movement: NanoVibronix Inc (NAOV) Sees a -5.63 Decrease, Closing at 0.45 - The Dwinnex
Closing Bell Recap: FMC Corp (FMC) Ends at 35.92, Reflecting a -33.53 Downturn - The Dwinnex
EyePoint stock jumps 10% on Duravyu study results - MSN
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Whirlpool Corp (WHR) Shares Rise Despite Market Challenges - The News Heater
BBB Foods Inc (TBBB) Stock Price and Analyst Predictions - The News Heater
NAOV’s price-to-free cash flow ratio: A closer look at its relevance - US Post News
NanoVibronix Inc (NAOV) is looking forward to a strong quarter - SETE News
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NanoVibronix Secures $12M Minimum Purchase Commitment for PainShield - MPO-mag
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy - ACCESS Newswire
NanoVibronix stock touches 52-week low at $0.44 amid market challenges - MSN
NanoVibronix stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix’s UroShield trial results hold potential to advance urinary care: GlobalData - Express Healthcare
NanoVibronix stock touches 52-week low at $0.46 amid market challenges - Investing.com Canada
NanoVibronix stock touches 52-week low at $0.46 amid market challenges By Investing.com - Investing.com South Africa
Septerna (NASDAQ: SEPN) Appoints Gil Labrucherie as Chief Financial Officer - Defense World
NanoVibronix (NASDAQ:NAOV) Enters into Securities Exchange AgreementOn January 7, 2025, NanoVibronix, Inc. filed an 8-K form with the Securities and Exchange Commission, disclosing its recent agreement with an institutional investor. The company en - Defense World
NanoVibronix advances medical device development By Investing.com - Investing.com Canada
NanoVibronix announces exchange agreement with investor By Investing.com - Investing.com
NanoVibronix advances medical device development - Investing.com
NanoVibronix Unveils Next-Gen PainShield and UroShield with Enhanced Therapy Features - StockTitan
Transforming catheter care: NanoVibronix completes successful UroShield US trial - Yahoo Finance
NanoVibronix Announces Completion of Pilot Phase of UroShield® Clinical Study at University of MichiganOn January 6, 2025, NanoVibronix Inc. (NASDAQ: NAOV) revealed the successful conclusion of the initial phase of a Randomized Control Trial study at - Defense World
NanoVibronix Advances UroShield® Trial and Receives Nasdaq Extension - TipRanks
NanoVibronix completes pilot study of UroShield - Mass Device
NanoVibronix “achieves goals” of US trial pilot phase with UroShield - Yahoo Finance
NanoVibronix, Inc. Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan - Marketscreener.com
Nanovibronix Inc (NAOV) 財務データ
収益
当期純利益
現金流量
EPS
1.16%
0.10%
大文字化:
|
ボリューム (24 時間):